Randomized trial · people
Melanotan I: full uptake under the skin, tanning in 3 men
Checked against the paper Randomized trialPublished by PepVault
The takeaway
This early human study found melanotan I under the skin reached the blood fully and tanned skin, while taken by mouth it was not detected in the blood.
- Kind
- Randomized trial
- Studied in
- People
- Number studied
- 3
- Published
- 1997
- Journal
- Biopharm Drug Dispos
What they tested
The team compared how melanotan I moves through the body and darkens skin when given into a vein, under the skin, or by mouth.
How the study was done
A small randomized crossover trial, where each person tried more than one route, in 3 male volunteers. They got 0.16 mg kg-1 into a vein or by mouth, or 0.08 to 0.21 mg kg-1 under the skin, on five days in a row for 2 weeks (ten doses). Blood levels and skin color were measured over time.

What they found
In these 3 men, the dose given under the skin was fully bioavailable (it all reached the blood) compared with the dose into a vein. No drug was detected in the blood after dosing by mouth. After dosing under the skin, the absorption half-life ranged from 0.07 to 0.79 h and the later elimination half-life from 0.8 to 1.7 h, and 3.9% or less of the dose turned up in urine. The forehead, arms, and neck tanned clearly after vein or under-the-skin dosing; tanning peaked 1 week after dosing and was still there 3 weeks after the ten doses ended, while side effects were minimal, mainly occasional stomach upset and facial flushing.
What it doesn’t show
Only 3 men took part, with 2 weeks of dosing. It cannot show how melanotan I works in women, in larger groups, or over longer use.
The paper
Ugwu et al. Skin pigmentation and pharmacokinetics of melanotan-I in humans. Biopharm Drug Dispos. 1997.
The compound
More studies on Melanotan I
- Melanotan I: more pain-free sun time in protoporphyria trialsRandomized trial · people · 2015
- Melanotan I plus UV-B: 48.64% vitiligo repigmentation at day 168Randomized trial · people · 2015
- Melanotan I: well tolerated in 6 acute stroke patientsClinical trial · people · 2023
- Melanotan II: erections in 17 of 20 men with erectile dysfunctionClinical trial · people · 2000
- Melanotan II: darker skin in 2 of 3 men in a small phase I trialClinical trial · people · 1996
- Melanotan II: oral melanoma case in a 22-year-old nasal spray userObservational study · people · 2025
- Every study on Melanotan I
Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.